CONDITIONS • WESTMINSTER, ARVADA, BROOMFIELD, THORTON & DENVER METRO
Coronary Artery Disease Treatment in Westminster, CO
Coronary artery disease is largely preventable and significantly reversible in its earlier stages. The standard management model focuses on medications and procedures that treat the consequences of the disease while leaving most of its actual drivers entirely unaddressed.
Whether you have been diagnosed with coronary artery disease, told you have significant cardiovascular risk factors, or are recovering from a cardiac event, the evidence is clear that the most powerful interventions available involve the same metabolic, nutritional, and lifestyle factors that conventional cardiology rarely has the time or the framework to address comprehensively. Medication and procedures are important. They work best alongside an intensive and individualized effort to address the root biology of the disease.
Same-Day & Same-Week Appointments Available
WE UNDERSTAND WHAT YOU'RE GOING THROUGH
A cardiac diagnosis changes everything. The life you had before the event and the one you have after it feel like different lives — and the medical system hands you a set of prescriptions and sends you home to figure out how to live in the new one.
For many people, a coronary artery disease diagnosis or a cardiac event is the first time they have been confronted with the reality that the body has been accumulating damage quietly, over decades, without obvious warning. The questions that follow are profound and often go unanswered: why did this happen to me? What did I do wrong, and what do I need to do differently? Is the medication enough, or is there more I should be doing? Am I going to be able to live fully or am I going to spend the rest of my life waiting for the next event? These are not just psychological questions. They are clinical questions, and they deserve comprehensive answers. Naturopathic medicine is uniquely positioned to provide those answers and to translate them into specific, actionable, and evidence-based interventions that work alongside conventional cardiac care to give the cardiovascular system the best possible environment for recovery and resilience.
WHO THIS PAGE IS FOR
-
People diagnosed with coronary artery disease who want to address it as comprehensively as possible alongside their cardiologist's care
-
People recovering from a heart attack, stent placement, or bypass surgery who want to optimize their recovery and reduce recurrence risk
-
People with significant cardiovascular risk factors — diabetes, high blood pressure, elevated inflammatory markers, family history — who want proactive, intensive risk reduction
-
People whose standard cardiac follow-up addresses medication compliance but not the metabolic and lifestyle drivers of the disease
-
People with statin side effects who want nutritional and metabolic support alongside their lipid management
-
People who are under the care of a cardiologist for their condition
THE PAIN CONNECTION
Chronic pain and coronary artery disease share many root drivers: systemic inflammation, insulin resistance, elevated cortisol from chronic stress, and physical inactivity from pain-limited movement. People managing chronic musculoskeletal pain are simultaneously carrying many of the cardiovascular system's primary risk factors. Anti-inflammatory medications taken for pain raise blood pressure and accelerate vascular aging.
At True Health Centers, treating the pain is cardiovascular treatment too. Resolving pain reduces NSAID use, lowers sympathetic nervous system activation, reduces systemic inflammation, and makes the physical activity that protects the heart genuinely possible.
WHAT YOU PROBABLY HAVEN'T BEEN TOLD
Coronary artery disease is primarily an inflammatory disease, not a cholesterol disease. The plaques that narrow arteries form at sites of vascular injury and inflammation. Cholesterol is a passenger at those sites, not the arsonist.
HOW CORONARY ARTERY DISEASE ACTUALLY DEVELOPS — AND WHY THE CHOLESTEROL STORY IS INCOMPLETE
Atherosclerosis — the buildup of plaques inside the coronary arteries — does not happen because cholesterol is circulating in the blood. It happens because the inner lining of the artery wall becomes damaged and inflamed, and cholesterol becomes trapped in that inflamed tissue as part of the body's repair response. The artery wall becomes damaged by several well-identified processes: oxidative stress from poor diet and metabolic dysfunction, mechanical stress from chronically elevated blood pressure, chemical irritation from elevated blood glucose and glycation, immune activation from chronic systemic inflammation, and endothelial dysfunction from chronic cortisol elevation and physical inactivity. When the artery wall is injured and inflamed, LDL cholesterol particles penetrate it, become oxidized, and trigger an immune response that produces the foam cells and fibrous caps of an atherosclerotic plaque. Reducing circulating LDL reduces the amount available to penetrate damaged walls. But it does not repair the walls, reduce the inflammation that drove the injury, or restore the endothelial function that protects the artery in the first place.
This is why the most powerful evidence for cardiovascular risk reduction comes not from lipid-lowering medication alone but from comprehensive lifestyle medicine: dietary patterns that reduce vascular inflammation, metabolic optimization that eliminates insulin resistance, targeted nutritional support for endothelial function, and stress management that reduces the cortisol-driven vascular aging that standard cardiac care almost never addresses. Medication is a meaningful and often necessary component of the risk reduction plan. It works best when the biology driving the disease is being addressed alongside it.
The inflammatory markers that actually predict cardiac events
High-sensitivity C-reactive protein (hsCRP) is one of the strongest independent predictors of cardiovascular events available, outperforming LDL cholesterol in multiple large studies. Homocysteine is a metabolic byproduct that directly damages arterial walls and is driven by B vitamin deficiency, specifically B6, B12, and folate. Lipoprotein(a) is a genetically determined lipid particle that is profoundly atherogenic and is not lowered by standard statin therapy. Oxidized LDL is the form of LDL that actually triggers the arterial wall injury, not LDL in total. None of these are included in the standard cardiac risk assessment. All of them are available from a comprehensive lab panel, and all of them point toward specific interventions that can meaningfully reduce the risk they represent.
A person with a normal LDL but elevated hsCRP, elevated homocysteine, and elevated lipoprotein(a) has a cardiovascular risk profile far more dangerous than their cholesterol number suggests — and standard care will not identify any of it.
Insulin resistance — the most modifiable cardiovascular risk factor most doctors don't test
Insulin resistance is now understood to be one of the most powerful drivers of cardiovascular disease. Elevated insulin directly promotes vascular smooth muscle proliferation — thickening the artery wall from the inside. It drives the formation of small, dense LDL particles that penetrate artery walls more easily than large LDL particles. It promotes sodium retention, raising blood pressure. It increases sympathetic nervous system tone. And it drives systemic inflammation through multiple pathways simultaneously. Fasting insulin is not included in standard cardiac risk assessment. HbA1c is often checked, but insulin resistance produces arterial damage for years before blood glucose becomes abnormal enough to register. Identifying insulin resistance early through a fasting insulin level is one of the highest-yield tests in preventive cardiology and one of the least commonly ordered.
A normal fasting glucose alongside an elevated fasting insulin indicates significant insulin resistance and substantially elevated cardiovascular risk — risk that is invisible to the standard cardiac panel.
What the diet evidence actually shows for cardiovascular disease
The dietary advice most cardiac patients receive — reduce saturated fat, eat more whole grains, follow a low-fat diet — is based on research that is now understood to be incomplete. The best evidence for cardiovascular risk reduction comes from dietary patterns that reduce systemic inflammation and insulin resistance. The Mediterranean dietary pattern, rich in olive oil, fish, nuts, vegetables, and legumes, has demonstrated significant reductions in cardiovascular events in clinical trials. Time-restricted eating and carbohydrate-conscious approaches that reduce post-meal insulin spikes have strong mechanistic support. Specific nutrients with evidence for cardiovascular benefit include omega-3 fatty acids (at therapeutic doses), magnesium, CoQ10, vitamin K2 for calcification prevention, and vitamin D for endothelial function. None of these are part of the standard cardiac dietary counseling framework, and the nuanced individualized guidance they require is rarely available in a standard cardiology follow-up appointment.
The PREDIMED trial demonstrated a 30 percent reduction in major cardiovascular events with a Mediterranean diet supplemented with olive oil or nuts — comparable to the benefit of adding a second blood pressure medication.
OUR APPROACH
Conventional care versus our approach
Cardiology is essential, and we fully support every aspect of the patient's medical cardiac management. Our role is to address what conventional cardiology does not have the time, testing scope, or framework to cover — the inflammatory biology, the metabolic drivers, the nutritional components, and the lifestyle factors that determine the trajectory of the disease more powerfully than medication alone.
The conventional approach
What most patients experience
-
Standard lipid panel, EKG, stress testing, and imaging to diagnose and stage the disease
-
Statin, aspirin, blood pressure medication, and other pharmaceuticals as indicate
-
Stenting or bypass surgery for significant arterial obstruction
-
General advice to exercise, reduce saturated fat, and manage stress
-
Inflammatory markers, insulin resistance, homocysteine, lipoprotein(a), and oxidized LDL rarely assessed
-
Statin-related CoQ10 depletion, nutritional cardiovascular support, and the gut-heart axis never addressed
Standard cardiology is essential and life-saving. Its limitation for many patients is that it treats the anatomical and lipid consequences of the disease without comprehensively addressing the inflammatory and metabolic biology that is driving it forward.
What we do differently
-
Advanced cardiovascular risk assessment: hsCRP, homocysteine, lipoprotein(a), oxidized LDL, LDL particle size, fasting insulin and HbA1c, and vitamin D — the markers that tell the actual inflammatory and metabolic story
-
Individualized dietary guidance grounded in the actual evidence for cardiovascular risk reduction: Mediterranean dietary principles, carbohydrate quality for insulin management, and specific anti-inflammatory food patterns
-
Evidence-based targeted supplementation: therapeutic omega-3s for triglyceride reduction and vascular inflammation, CoQ10 for statin-depleted patients and cardiac energy, magnesium for vascular tone and arrhythmia prevention, vitamin K2 for arterial calcification reduction, and B vitamins for homocysteine management
-
Insulin resistance correction as a primary cardiovascular intervention: metabolic optimization through carbohydrate-conscious diet, targeted supplementation, IR sauna for insulin sensitivity, and gut health restoration
-
Autonomic regulation to reduce chronic sympathetic overactivation — through constitutional hydrotherapy and chiropractic care — lowering the cortisol-driven vascular damage and blood pressure elevation that standard cardiac management treats pharmacologically rather than at the source
-
For patients with concurrent chronic pain: resolving the pain as a cardiovascular intervention — eliminating NSAID use that accelerates vascular aging, reducing the sympathetic activation maintaining elevated heart rate and blood pressure, and making protective physical activity genuinely achievable
We work collaboratively with the patient's gastroenterologist and do not alter any medical management. Our role is the comprehensive recovery support that standard celiac follow-up does not provide.
WHAT MAKES OUR APPROACH DIFFERENT — IN A SINGLE PARAGRAPH
Standard cardiology saves lives in acute situations and reduces risk through medication. Our approach addresses the biology that creates the risk in the first place — the vascular inflammation, the insulin resistance, the oxidative stress, the cortisol-driven vascular aging, and the specific nutritional deficiencies that both accelerate the disease and undermine the body's capacity for vascular repair. For patients recovering from a cardiac event, this work is the difference between following a prescription and genuinely changing the cardiovascular trajectory. For patients managing risk factors before an event, it is some of the most impactful preventive medicine available. And for patients managing both coronary artery disease and chronic pain, we treat both as the intertwined conditions they are — because the same metabolic and inflammatory environment is driving both, and addressing it comprehensively is the only approach that produces lasting improvement in either.
KEY CARDIOVASCULAR INTERVENTIONS BEYOND MEDICATION
The evidence-based natural interventions with the strongest cardiovascular data — and that standard cardiac care almost never applies
These are not fringe interventions. Each has a robust evidence base for cardiovascular benefit. Most are not part of standard cardiology management because they fall outside the pharmaceutical framework rather than because the evidence is lacking.
Omega-3 fatty acids
At therapeutic doses (2 to 4 grams of EPA plus DHA daily), omega-3 fatty acids reduce triglycerides, lower hsCRP, reduce platelet aggregation, stabilize heart rhythm, and lower cardiovascular event risk in established coronary artery disease patients. The REDUCE-IT trial demonstrated a 25 percent reduction in cardiovascular events with high-dose EPA specifically. The dose matters — the amount in a standard fish oil capsule is insufficient for these effects.
CoQ10
CoQ10 is essential for mitochondrial energy production in cardiac muscle cells. Statin medications deplete CoQ10 by blocking the same liver enzyme that produces it alongside cholesterol. Clinical trials have shown CoQ10 supplementation reduces statin-related muscle side effects and improves cardiac function in heart failure. For any patient on a statin, CoQ10 is a standard of care in several countries and a near-universal omission in the United States.
Vitamin K2 and arterial calcification
Vitamin K2 activates the proteins that prevent calcium from depositing in artery walls — a process called vascular calcification that is a direct measure of atherosclerotic plaque burden. Paradoxically, the vitamin D supplementation commonly used in cardiovascular risk reduction can worsen calcification if vitamin K2 is absent, because vitamin D increases calcium absorption without the K2 needed to direct it to bones rather than arteries. The K2-cardiovascular connection is one of the most clinically important nutritional insights in preventive cardiology and is almost universally absent from standard care.
TAKE THE NEXT STEP
Your cardiologist treats the arteries. We address the biology that is affecting them. Both are necessary.
Advanced cardiovascular risk assessment, metabolic optimization, targeted nutritional support, and integrated pain and lifestyle management.
Not sure where to begin? Give us a call and we'll help you choose the best first step.